In this work, we have developed DOX‐loaded nanoMIPs for their targeted delivery to ERα positive BC cell lines to improve breast cancer treatment via double imprinting with an epitope of ERα in the presence of DOX. This evidence concerns the gene ESR1 and breast cancer.